In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.


The free consultation period for this content is over.

It is now only available year-round to EACVI Silver Members, Fellows of the ESC and Young combined Members

Evolution of left ventricular longitudinal and radial function after ST-elevation myocardial infarction

Session Poster session 1

Speaker Marcus Carlsson

Congress : EuroCMR 2019

  • Topic : imaging
  • Sub-topic : Cardiac Magnetic Resonance: Systolic and Diastolic Function
  • Session type : Poster Session
  • FP Number : P155

Authors : U Pahlm (Lund,SE), E Ostenfeld (Lund,SE), F Seemann (Lund,SE), D Erlinge (Lund,SE), E Heiberg (Lund,SE), H Engblom (Lund,SE), H Arheden (Lund,SE), M Carlsson (Lund,SE)

Authors:
U Pahlm1 , E Ostenfeld1 , F Seemann1 , D Erlinge2 , E Heiberg1 , H Engblom1 , H Arheden1 , M Carlsson1 , 1Lund University, Clinical Physiology - Lund - Sweden , 2Lund University, Cardiology - Lund - Sweden ,

Citation:
European Heart Journal - Cardiovascular Imaging ( 2019 ) 20 ( Supplement 2 ), ii108

Background: Atrioventricular plane displacement (AVPD) reflects longitudinal left ventricular (LV) systolic function, and wall thickening (WT) regional radial LV function. AVPD is decreased globally and regionally in both infarcted and remote segments of the LV within a week of ST-elevation myocardial infarction (STEMI).

Purpose: We aimed to investigate how AVPD and WT are affected globally and regionally from the sub-acute to the chronic phase after STEMI.

Methods: Patients from the CHILL-MI study who underwent cardiovascular magnetic resonance imaging 2-6 days and 6 months after STEMI (n=77, 58±10 years) and healthy controls (n=20, 62±11 years) were included. Left ventricular volumes and regional WT were quantified in short-axis and AVPD in 3 long-axis cine images.

Results: Infarct size decreased from 17±10% to 10±6% (p<0.001) and ejection fraction (EF) increased from 48±8% to 52±9% (p<0.001). This was accompanied by a global AVPD decrease in both the sub-acute (12±2 mm, p<0.001) and the chronic phase (13±2 mm, p<0.001) compared to controls (15±2 mm) with a partial recovery of AVPD (p<0.001) in the chronic phase. Patients with left anterior descending (LAD) and right coronary artery (RCA) infarcts had decreased AVPD in the chronic phase in both infarcted and remote segments.

Mean WT was decreased in patients with LAD infarction both in the sub-acute and the chronic phase in both infarcted and remote segments. The decrease in WT in patients with RCA and left circumflex (LCx) infarcts was more affected in the infarcted segments especially in the chronic phase.

Conclusion:  Assessment of regional longitudinal and radial function after STEMI is complex. Decrease in regional function can be seen in segments without infarction, even in the chronic phase. This information is important to consider when combining functional measurements with infarct quantification for diagnosis of post-ischemic stunning and hibernation.

Figure 1. AVPD in mm and Wall thickening (WT) in % for each wall in patients with infarctions in LAD, LCx and RCA territory.  Controls are showed for comparison. Chronic phase vs controls: * p<0.05, ** p<0.01, *** p<0.001. Sub-acute vs. cronic phase † p<0.05, †† p<0.01, ††† p<0.001



Based on your interests

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are